Literature DB >> 21084564

REGgamma modulates p53 activity by regulating its cellular localization.

Jian Liu1, Guowu Yu, Yanyan Zhao, Dengpan Zhao, Ying Wang, Lu Wang, Jiang Liu, Lei Li, Yu Zeng, Yongyan Dang, Chuangui Wang, Guang Gao, Weiwen Long, David M Lonard, Shanlou Qiao, Ming-Jer Tsai, Bianhong Zhang, Honglin Luo, Xiaotao Li.   

Abstract

The proteasome activator REGγ mediates a shortcut for the destruction of intact mammalian proteins. The biological roles of REGγ and the underlying mechanisms are not fully understood. Here we provide evidence that REGγ regulates cellular distribution of p53 by facilitating its multiple monoubiquitylation and subsequent nuclear export and degradation. We also show that inhibition of p53 tetramerization by REGγ might further enhance cytoplasmic relocation of p53 and reduce active p53 in the nucleus. Furthermore, multiple monoubiquitylation of p53 enhances its physical interaction with HDM2 and probably facilitates subsequent polyubiquitylation of p53, suggesting that monoubiquitylation can act as a signal for p53 degradation. Depletion of REGγ sensitizes cells to stress-induced apoptosis, validating its crucial role in the control of apoptosis, probably through regulation of p53 function. Using a mouse xenograft model, we show that REGγ knockdown results in a significant reduction of tumor growth, suggesting an important role for REGγ in tumor development. Our study therefore demonstrates that REGγ-mediated inactivation of p53 is one of the mechanisms involved in cancer progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084564      PMCID: PMC2987440          DOI: 10.1242/jcs.067405

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  28 in total

1.  Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.

Authors:  Muyang Li; Christopher L Brooks; Foon Wu-Baer; Delin Chen; Richard Baer; Wei Gu
Journal:  Science       Date:  2003-12-12       Impact factor: 47.728

2.  Immune defects in 28-kDa proteasome activator gamma-deficient mice.

Authors:  Lance F Barton; Herbert A Runnels; Todd D Schell; Yunjung Cho; Reta Gibbons; Satvir S Tevethia; George S Deepe; John J Monaco
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

3.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.

Authors:  R Honda; H Tanaka; H Yasuda
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

4.  C-terminal ubiquitination of p53 contributes to nuclear export.

Authors:  M A Lohrum; D B Woods; R L Ludwig; E Bálint; K H Vousden
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

5.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

6.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

7.  ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

Authors:  Y Zhang; Y Xiong; W G Yarbrough
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

8.  The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

Authors:  J Pomerantz; N Schreiber-Agus; N J Liégeois; A Silverman; L Alland; L Chin; J Potes; K Chen; I Orlow; H W Lee; C Cordon-Cardo; R A DePinho
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

9.  Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells.

Authors:  Masahiko Nishizaki; Ji-Ichiro Sasaki; Bingliang Fang; Edward N Atkinson; John D Minna; Jack A Roth; Lin Ji
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

Review 10.  The common and distinct target genes of the p53 family transcription factors.

Authors:  K Harms; S Nozell; X Chen
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

View more
  36 in total

1.  Protein kinase Cα (PKCα) regulates p53 localization and melanoma cell survival downstream of integrin αv in three-dimensional collagen and in vivo.

Authors:  Stephen D Smith; Martin Enge; Wenjie Bao; Minna Thullberg; Tânia D F Costa; Helene Olofsson; Behxhet Gashi; Galina Selivanova; Staffan Strömblad
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

2.  Knockdown of FOXP1 promotes the development of lung adenocarcinoma.

Authors:  Hua Sheng; Xiangyang Li; Yi Xu
Journal:  Cancer Biol Ther       Date:  2018-11-08       Impact factor: 4.742

3.  PKA turnover by the REGγ-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis.

Authors:  Shuang Liu; Li Lai; Qiuhong Zuo; Fujun Dai; Lin Wu; Yan Wang; Qingxia Zhou; Jian Liu; Jiang Liu; Lei Li; Qingxiang Lin; Chad J Creighton; Myra Grace Costello; Shixia Huang; Caifeng Jia; Lujian Liao; Honglin Luo; Junjiang Fu; Mingyao Liu; Zhengfang Yi; Jianru Xiao; Xiaotao Li
Journal:  J Mol Cell Cardiol       Date:  2014-02-20       Impact factor: 5.000

4.  Subcellular proteomics reveals a role for nucleo-cytoplasmic trafficking at the DNA replication origin activation checkpoint.

Authors:  Claire M Mulvey; Slavica Tudzarova; Mark Crawford; Gareth H Williams; Kai Stoeber; Jasminka Godovac-Zimmermann
Journal:  J Proteome Res       Date:  2013-02-06       Impact factor: 4.466

5.  Inhibition of Proteasome Activity Induces Formation of Alternative Proteasome Complexes.

Authors:  Vanessa Welk; Olivier Coux; Vera Kleene; Claire Abeza; Dietrich Trümbach; Oliver Eickelberg; Silke Meiners
Journal:  J Biol Chem       Date:  2016-04-18       Impact factor: 5.157

6.  Expression of REGγ in atherosclerotic plaques and promotes endothelial cells apoptosis via the cyclophilin A pathway indicates functional implications in atherogenesis.

Authors:  Yifan Xie; Xiaotao Li; Junbo Ge
Journal:  Cell Cycle       Date:  2019-07-07       Impact factor: 4.534

7.  Involvement of the nuclear proteasome activator PA28γ in the cellular response to DNA double-strand breaks.

Authors:  Adva Levy-Barda; Yaniv Lerenthal; Anthony J Davis; Young Min Chung; Jeroen Essers; Zhengping Shao; Nicole van Vliet; David J Chen; Mickey C-T Hu; Roland Kanaar; Yael Ziv; Yosef Shiloh
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

8.  Upregulation of GSK3β Contributes to Brain Disorders in Elderly REGγ-knockout Mice.

Authors:  Yiqing Lv; Bo Meng; Hao Dong; Tiantian Jing; Nan Wu; Yingying Yang; Lan Huang; Robb E Moses; Bert W O'Malley; Bing Mei; Xiaotao Li
Journal:  Neuropsychopharmacology       Date:  2015-09-15       Impact factor: 7.853

9.  High expression of REGγ is associated with metastasis and poor prognosis of patients with breast cancer.

Authors:  Fan Chai; Yan Liang; Jiong Bi; Li Chen; Fan Zhang; Youhong Cui; Xiuwu Bian; Jun Jiang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

10.  Site-specific acetylation of the proteasome activator REGγ directs its heptameric structure and functions.

Authors:  Jiang Liu; Ying Wang; Lei Li; Li Zhou; Haibin Wei; Qingxia Zhou; Jian Liu; Weicang Wang; Lei Ji; Peipei Shan; Yan Wang; Yuanyuan Yang; Sung Yun Jung; Pei Zhang; Chuangui Wang; Weiwen Long; Bianhong Zhang; Xiaotao Li
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.